Florey researchers to pursue first-in-clinic treatment for severe infant epilepsy
8 May 2020 Researchers at the Florey, in collaboration with the University of Melbourne, will pursue a potentially life-changing precision medicine treatment for children with severe forms of epilepsy, thanks to a new multi-year grant awarded from the…
AdAlta update: Dr Tim Oldham interviewed by Pitt Street Research
8 May, 2020 Our CEO, Dr Tim Oldham recently sat down with Stuart Roberts of Pitt Street research to talk about AdAlta’s growth strategy and upcoming Phase 1 clinical trials of lead candidate, AD-214. In the interview, Dr…
Killing ‘sleeper cells’ may enhance breast cancer therapy
7 May 2020 The anti-cancer medicine venetoclax could improve the current therapy for estrogen receptor-positive (ER+) breast cancer – the most common form of breast cancer in Australia – according to preclinical studies led by Walter and Eliza…
Tessara Therapeutics Raises $2.7 Million to Develop Mimetic Brain Tissue
7 May 2020 · Tessara™ Therapeutics Pty Ltd closed their Round 1 capital raise with $2.7M invested, significantly over-subscribed by Australian and New Zealand-based sophisticated investors. · A New South Wales-based syndicate, including medical specialists and a neurosurgeon,…
Sienna enters New Zealand market with its hTERT IVD
6 May 2020 Sienna Cancer Diagnostics Ltd (ASX:SDX) (“Sienna” or “the Company”) is pleased to announce the appointment of Scientle Innovations (“Scientle”) as its exclusive distributor in New Zealand. The distribution agreement provides Scientle with the right to…
CSL Behring Australia Commences Development of Treatment for Serious Cases of COVID-19
6 May 2020 CSL Behring Australia, a subsidiary of CSL Limited, today announced that it will begin immediate onshore development of an anti-SARS-CoV-2 plasma product with the potential to treat people with serious complications of COVID-19, particularly those…
Over $33 million to boost genomics research into cancers and to combat children’s diseases
6 May 2020 Via the Hon Greg Hunt MP The Morrison Government has awarded over $33 million to Australia’s best and brightest researchers to combat high mortality and low survivability cancers and diseases, improve paediatric acute care using…
10M grant enables MCRI’s BCG vaccine trial to expand internationally, enrol 10,000 healthcare workers
5 May 2020 An A$10 million grant from the Bill & Melinda Gates Foundation will allow the Murdoch Children’s Research Institute’s (MCRI) clinical trial of the BCG vaccine against COVID-19 to extend to 10,000 healthcare workers across Australia, Spain and The Netherlands.…
VivaZome licenses University of Adelaide stem cell technology
5 May 2020 Melbourne and Adelaide, Australia: VivaZome Therapeutics Pty Ltd (“VivaZome”) and the University of Adelaide today announced that they have entered into a series of agreements encompassing licensing of technology, access to stem cells and conduct…
Saving Jobs And Reducing The Burden On Businesses And Families
5 May 2020 Via the Victorian Government The Victorian Government will provide a further $491 million in tax relief to help save businesses and jobs, and freeze a host of fees, charges and levies to reduce the financial…
New Research Unveils the Secret Life of White Blood Cells
4 May 2020 New research led by scientists at the Australian Regenerative Medicine Institute (ARMI) has unveiled how white blood cells move and carry out their functions at the cellular and subcellular level – at a resolution at…
ATO support for people affected by COVID-19
4 May 2020 Via Senator the Hon Michaela Cash, Minister for Employment, Skills, Small and Family Business The Australian Taxation Office (ATO) is implementing a range of COVID-19 support measures for businesses and employers and for individuals and…
